ICUI insider transaction filings
ICU MEDICAL INC/DE — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-13. Screen ICUI transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-13 | 4 | Woolson Daniel — VP, GM-Infusion Capital | Sale (S): 5,417 @ $181.33 | EDGAR |
| 2026-08-12 | 4 | Sousa Ben — Chief Information Officer | Sale (S): 2,250 @ $178.32 | EDGAR |
| 2026-08-11 | 4 | Voigtlander Christian B. — Chief Operating Officer | Sale (S): 8,929 @ $182.93 | EDGAR |
| 2026-08-11 | 4 | FINNEY ELISHA W — Director | Sale (S): 378 @ $182.48 | EDGAR |
| 2026-05-22 | 4 | Woolson Daniel — President | Sale (S): 2,123 @ $132.21 | EDGAR |
| 2026-05-15 | 4 | Sanzone Virginia Ruth — VP, General Counsel | Sale (S): 2,447 @ $124.08 | EDGAR |
| 2026-05-13 | 4 | Hernandez Laurie — Director | Option exercise (M): 1,254 @ $0 · Option exercise (M): 1,254 (derivative) @ $0 · Grant/award (A): 1,475 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | Greenberg David C. — Director | Option exercise (M): 2,424 @ $101.06 · Sale (S): 2,424 @ $122.91 · Option exercise (M): 1,254 @ $0 · Option exercise (M): 2,424 (derivative) @ $0 · Option exercise (M): 1,254 (derivative) @ $0 · Grant/award (A): 1,475 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | Abbey Donald — Director | Option exercise (M): 1,254 @ $0 · Option exercise (M): 1,254 (derivative) @ $0 · Grant/award (A): 1,475 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | KENNEDY KOLLEEN T — Director | Option exercise (M): 1,254 @ $0 · Option exercise (M): 1,254 (derivative) @ $0 · Grant/award (A): 1,475 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | Hoffmeister David F — Director | Option exercise (M): 1,254 @ $0 · Option exercise (M): 1,254 (derivative) @ $0 · Grant/award (A): 1,475 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | FINNEY ELISHA W — Director | Option exercise (M): 1,254 @ $0 · Option exercise (M): 1,254 (derivative) @ $0 · Grant/award (A): 1,475 (derivative) @ $0 | EDGAR |
| 2026-03-26 | 4 | Abbey Donald — Director | Other (J): 704 @ $0 | EDGAR |
| 2026-03-16 | 4 | Sousa Ben — Chief Information Officer | Option exercise (M): 1,300 @ $0 · Tax withholding (F): 718 @ $125.85 · Option exercise (M): 1,300 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Bonnell Brian Michael — Chief Financial Officer | Option exercise (M): 11,400 @ $0 · Tax withholding (F): 5,800 @ $125.85 · Option exercise (M): 3,248 @ $0 · Tax withholding (F): 1,795 @ $125.85 · Option exercise (M): 3,248 (derivative) @ $0 · Option exercise (M): 11,400 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Voigtlander Christian B. — Chief Operating Officer | Option exercise (M): 11,400 @ $0 · Tax withholding (F): 6,301 @ $125.85 · Option exercise (M): 3,248 @ $0 · Tax withholding (F): 1,795 @ $125.85 · Option exercise (M): 3,248 (derivative) @ $0 · Option exercise (M): 11,400 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Woolson Daniel — VP, GM-Infusion Capital | Option exercise (M): 2,924 @ $0 · Tax withholding (F): 1,295 @ $125.85 · Option exercise (M): 2,924 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Sanzone Virginia Ruth — VP, General Counsel | Option exercise (M): 5,700 @ $0 · Tax withholding (F): 3,150 @ $125.85 · Option exercise (M): 1,624 @ $0 · Tax withholding (F): 897 @ $125.85 · Option exercise (M): 1,624 (derivative) @ $0 · Option exercise (M): 5,700 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Jain Vivek — Chairman and CEO, Director | Option exercise (M): 17,100 @ $0 · Tax withholding (F): 9,452 @ $125.85 · Option exercise (M): 4,872 @ $0 · Tax withholding (F): 2,693 @ $125.85 · Option exercise (M): 4,872 (derivative) @ $0 · Option exercise (M): 17,100 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Sousa Ben — Chief Information Officer | Option exercise (M): 1,409 @ $0 · Tax withholding (F): 782 @ $132 · Option exercise (M): 7,177 @ $0 · Tax withholding (F): 3,967 @ $132 · Option exercise (M): 957 @ $0 · Tax withholding (F): 529 @ $132 · +3 more | EDGAR |
| 2026-03-09 | 4 | Bonnell Brian Michael — Chief Financial Officer | Option exercise (M): 3,522 @ $0 · Tax withholding (F): 1,263 @ $0 · Option exercise (M): 71,757 @ $0 · Tax withholding (F): 39,667 @ $132 · Option exercise (M): 3,522 (derivative) @ $0 · Option exercise (M): 71,757 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Voigtlander Christian B. — Chief Operating Officer | Option exercise (M): 3,522 @ $0 · Tax withholding (F): 1,946 @ $132 · Option exercise (M): 71,757 @ $0 · Tax withholding (F): 39,667 @ $132 · Option exercise (M): 3,522 (derivative) @ $0 · Option exercise (M): 71,757 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Woolson Daniel — VP, GM-Infusion Capital | Option exercise (M): 1,585 @ $0 · Tax withholding (F): 702 @ $132 · Option exercise (M): 16,147 @ $0 · Tax withholding (F): 6,877 @ $132 · Option exercise (M): 2,153 @ $0 · Tax withholding (F): 630 @ $132 · +3 more | EDGAR |
| 2026-03-09 | 4 | Sanzone Virginia Ruth — VP, General Counsel | Option exercise (M): 2,348 @ $0 · Tax withholding (F): 1,297 @ $132 · Option exercise (M): 23,917 @ $0 · Tax withholding (F): 13,221 @ $132 · Option exercise (M): 3,189 @ $0 · Tax withholding (F): 1,762 @ $132 · +3 more | EDGAR |
| 2026-03-09 | 4 | Jain Vivek — Chairman and CEO, Director | Option exercise (M): 5,282 @ $0 · Tax withholding (F): 2,919 @ $0 · Option exercise (M): 107,635 @ $0 · Tax withholding (F): 59,500 @ $132 · Option exercise (M): 5,282 (derivative) @ $0 · Option exercise (M): 107,635 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | Woolson Daniel — VP, GM-Infusion Capital | Sale (S): 2,897 @ $152.35 | EDGAR |
| 2025-11-12 | 4 | Sanzone Virginia Ruth — VP, General Counsel | Sale (S): 930 @ $142.34 | EDGAR |
| 2025-11-12 | 4 | FINNEY ELISHA W — Director | Option exercise (M): 1,285 @ $103.76 · Sale (S): 1,285 @ $140.42 · Option exercise (M): 1,285 (derivative) @ $0 | EDGAR |
| 2025-09-15 | 4 | Jain Vivek — Chairman and CEO, Director | Gift (G): 63,641 @ $0 · Gift (G): 63,641 @ $0 | EDGAR |
| 2025-08-27 | 4 | Greenberg David C. — Director | Purchase (P): 602 @ $126.14 · Purchase (P): 598 @ $126.69 | EDGAR |
| 2025-08-14 | 4 | Jain Vivek — Chairman and CEO, Director | Purchase (P): 2,378 @ $112.12 · Purchase (P): 19,551 @ $112.92 | EDGAR |
| 2025-05-30 | 4 | Sanzone Virginia Ruth — VP, General Counsel | Sale (S): 700 @ $133.62 | EDGAR |
| 2025-05-28 | 4 | Voigtlander Christian B. — Chief Operating Officer | Option exercise (M): 5,555 @ $96.83 · Sale (S): 4,945 @ $131 · Option exercise (M): 5,560 @ $96.83 · Sale (S): 4,985 @ $128.50 · Option exercise (M): 5,555 (derivative) @ $0 · Option exercise (M): 5,560 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Voigtlander Christian B. — Chief Operating Officer | Option exercise (M): 5,555 @ $96.83 · Sale (S): 4,959 @ $130.03 · Option exercise (M): 5,555 @ $96.83 · Sale (S): 4,959 @ $130 · Option exercise (M): 5,555 (derivative) @ $0 · Option exercise (M): 5,555 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | Voigtlander Christian B. — Chief Operating Officer | Option exercise (M): 5,555 @ $96.83 · Sale (S): 4,871 @ $137.11 · Option exercise (M): 5,555 @ $96.83 · Sale (S): 4,917 @ $133 · Option exercise (M): 5,555 (derivative) @ $0 · Option exercise (M): 5,555 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | FINNEY ELISHA W — Director | Sale (S): 600 @ $138.92 | EDGAR |
| 2025-05-19 | 4 | Voigtlander Christian B. — Chief Operating Officer | Option exercise (M): 5,555 @ $96.83 · Sale (S): 5,555 @ $140 · Option exercise (M): 5,555 @ $96.83 · Sale (S): 5,555 @ $138.00 · Option exercise (M): 5,555 (derivative) @ $0 · Option exercise (M): 5,555 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Sousa Ben — Chief Information Officer | Sale (S): 2,000 @ $137.36 | EDGAR |
| 2025-05-15 | 4 | Voigtlander Christian B. — Chief Operating Officer | Option exercise (M): 5,556 @ $96.83 · Sale (S): 5,556 @ $138.65 · Option exercise (M): 5,555 @ $96.83 · Sale (S): 5,555 @ $135.55 · Option exercise (M): 5,556 (derivative) @ $0 · Option exercise (M): 5,555 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | FINNEY ELISHA W — Director | Option exercise (M): 1,723 @ $0 · Grant/award (A): 1,254 (derivative) @ $0 · Option exercise (M): 1,723 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | Hernandez Laurie — Director | Option exercise (M): 1,723 @ $0 · Option exercise (M): 1,723 (derivative) @ $0 · Grant/award (A): 1,254 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | Greenberg David C. — Director | Option exercise (M): 1,723 @ $0 · Option exercise (M): 1,942 @ $94.68 · Sale (S): 1,942 @ $143.66 · Option exercise (M): 1,723 (derivative) @ $0 · Grant/award (A): 1,254 (derivative) @ $0 · Option exercise (M): 1,942 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | Abbey Donald — Director | Option exercise (M): 1,723 @ $0 · Grant/award (A): 1,254 (derivative) @ $0 · Option exercise (M): 1,723 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | KENNEDY KOLLEEN T — Director | Option exercise (M): 1,723 @ $0 · Grant/award (A): 1,254 (derivative) @ $0 · Option exercise (M): 1,723 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | Hoffmeister David F — Director | Option exercise (M): 1,723 @ $0 · Grant/award (A): 1,254 (derivative) @ $0 · Option exercise (M): 1,723 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | Sousa Ben — Chief Information Officer | Option exercise (M): 1,299 @ $0 · Tax withholding (F): 716 @ $143.45 · Option exercise (M): 1,299 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | Bonnell Brian Michael — Chief Financial Officer | Option exercise (M): 3,248 @ $0 · Option exercise (M): 3,248 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | Voigtlander Christian B. — Chief Operating Officer | Option exercise (M): 3,248 @ $0 · Tax withholding (F): 1,792 @ $143.45 · Option exercise (M): 3,248 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | Woolson Daniel — VP, GM-Infusion Capital | Option exercise (M): 2,923 @ $0 · Tax withholding (F): 1,294 @ $143.45 · Option exercise (M): 2,923 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | Sanzone Virginia Ruth — VP, General Counsel | Option exercise (M): 1,624 @ $0 · Tax withholding (F): 898 @ $143.45 · Option exercise (M): 1,624 (derivative) @ $0 | EDGAR |
Recent 8-K events — ICU MEDICAL INC/DE
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-18 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-20 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-19 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-02-27 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ICUI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →